EBV+ gastric cancer cell lines (YCCEL1, SNU719) and EBV− lines (AGS, SNU16, MKN74) were treated with a DNA methyl-transferase inhibitor (DNMT), decitabine (DCB), for three days followed by RNA sequencing to identify EBV-specific responses. This evidence concerns the gene DNMT1 and gastric cancer.